Skip to main content

Publications

featured publications

  • Early C-reactive protein kinetics predicts immunotherapy response in non-small cell lung cancer in the phase III OAK trial.

    JNCI cancer spectrum

    Authors: Jonas Saal, Tobias Bald, Markus Eckstein, Manuel Ritter, Peter Brossart, Jörg Ellinger, Michael Hölzel, Niklas Klümper

  • The pipeline for drugs for control and elimination of neglected tropical diseases: 1. Anti-infective drugs for regulatory registration.

    Parasites & vectors

    Authors: Kenneth M Pfarr, Anna K Krome, Issraa Al-Obaidi, Hannah Batchelor, Michel Vaillant, Achim Hoerauf, Nicholas O Opoku, Annette C Kuesel

  • Increased HIV Incidence in Microfilaria Positive Individuals in Tanzania.

    Pathogens (Basel, Switzerland)

    Authors: Jonathan Mnkai, Manuel Ritter, Lucas Maganga, Leonard Maboko, Willyhelmina Olomi, Petra Clowes, Jessica Minich, Agola Eric Lelo, Daniel Kariuki, Alexander Yaw Debrah, Christof Geldmacher, Michael Hoelscher, Elmar Saathoff, Mkunde Chachage, Kenneth Pfarr, Achim Hoerauf, Inge Kroidl

  • Visual impairment and retinal and brain neurodegeneration: A population-based study.

    Human brain mapping

    Authors: Davide Garzone, Robert P Finger, Matthias M Mauschitz, Alexandra Koch, Martin Reuter, Monique M B Breteler, N Ahmad Aziz

  • Brain reserve contributes to distinguishing preclinical Alzheimer's stages 1 and 2.

    Alzheimer's research & therapy

    Authors: Zerrin Yildirim, Firuze Delen, David Berron, Hannah Baumeister, Gabriel Ziegler, Hartmut Schütze, Wenzel Glanz, Laura Dobisch, Oliver Peters, Silka Dawn Freiesleben, Luisa-Sophie Schneider, Josef Priller, Eike Jakob Spruth, Anja Schneider, Klaus Fliessbach, Jens Wiltfang, Björn-Hendrik Schott, Dix Meiberth, Katharina Buerger, Daniel Janowitz, Robert Perneczky, Boris-Stephan Rauchmann, Stefan Teipel, Ingo Kilimann, Christoph Laske, Matthias H Munk, Annika Spottke, Nina Roy, Michael Heneka, Frederic Brosseron, Michael Wagner, Sandra Roeske, Alfredo Ramirez, Michael Ewers, Peter Dechent, Stefan Hetzer, Klaus Scheffler, Luca Kleineidam, Steffen Wolfsgruber, Renat Yakupov, Matthias Schmid, Moritz Berger, Hakan Gurvit, Frank Jessen, Emrah Duzel

  • Post hoc longitudinal assessment of efficacy and safety of recombinant factor IX Fc fusion protein in hemophilia B.

    Blood advances

    Authors: Amy D Shapiro, Roshni Daniel Kulkarni, Margaret V Ragni, Herve Chambost, Johnny N Mahlangu, Johannes Oldenburg, Beatrice Nolan, Margareth C Ozelo, Meredith C Foster, Annemieke Willemze, Chris Barnowski, Nisha Jain, Bent Winding, Jennifer Dumont, Stefan Lethagen, Chris Barnes, K John Pasi

  • Replication and mediation of the association between the metabolome and clinical markers of metabolic health in an adolescent cohort study.

    Scientific reports

    Authors: Christian Brachem, Leonie Weinhold, Ute Alexy, Matthias Schmid, Kolade Oluwagbemigun, Ute Nöthlings

  • Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN).

    Leukemia

    Authors: Frank Stegelmann, Lino L Teichmann, Florian H Heidel, Carl C Crodel, Thomas Ernst, Sebastian Kreil, Andreas Reiter, Sara Otten, Stefanie Schauer, Ruth-Miriam Körber, Kim Kricheldorf, Susanne Isfort, Hartmut Döhner, Tim H Brümmendorf, Martin Griesshammer, Konstanze Döhner, Steffen Koschmieder

  • Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A.

    The New England journal of medicine

    Authors: Johnny Mahlangu, Radoslaw Kaczmarek, Annette von Drygalski, Susan Shapiro, Sheng-Chieh Chou, Margareth C Ozelo, Gili Kenet, Flora Peyvandi, Michael Wang, Bella Madan, Nigel S Key, Michael Laffan, Amy L Dunn, Jane Mason, Doris V Quon, Emily Symington, Andrew D Leavitt, Johannes Oldenburg, Hervé Chambost, Mark T Reding, Kala Jayaram, Hua Yu, Reena Mahajan, Konstantia-Maria Chavele, Divya B Reddy, Joshua Henshaw, Tara M Robinson, Wing Yen Wong, Steven W Pipe

  • Health-Related Quality of Life as Assessed by the EQ-5D-5L Predicts Outcomes of Patients Treated with Azacitidine-A Prospective Cohort Study by the AGMT.

    Cancers

    Authors: Lisa Pleyer, Sonja Heibl, Christoph Tinchon, Sonia Vallet, Martin Schreder, Thomas Melchardt, Norbert Stute, Kim Tamara Föhrenbach Quiroz, Michael Leisch, Alexander Egle, Lukas Scagnetti, Dominik Wolf, Richard Beswick, Manuel Drost, Julian Larcher-Senn, Thomas Grochtdreis, Marc Vaisband, Jan Hasenauer, Nadja Zaborsky, Richard Greil, Reinhard Stauder